U. Minnesota Prof Calls BS on GSK Release: Making Patient-Level Data Available

Mad In America has;
Glaxo Makes Patient-Level Data Available From Drug Trials

"After years of controversy over access to trial data, GlaxoSmithKline announced today that it will make patient-level data from its drug trials available to researchers. “This doesn’t sound like transparency to me,” said MIA blogger Carl Elliott, a professor at the Center for Bioethics at the University of Minnesota, “It sounds like a PR tactic. If I suspect that researchers on a GSK-funded trial have rigged the design or cooked the data, is this ‘independent panel of experts’ going to give me access?”

Press Release →

Glaxo Peels Back Curtain On Drug Data (Pharmalot)
Glaxo Opens Door to Data on Research (NY Times)

Thank You Mad In America, and Professor Elliot